Advanced Search

Show simple item record

dc.contributor.authorKarakaya, Burcu Kısa
dc.contributor.authorÇağlar, Gamze Sinem
dc.contributor.authorCandar, Tuba
dc.contributor.authorÇelik, Hatice Kansu
dc.contributor.authorTaşçı, Yasemin
dc.contributor.authorErkaya, Salim
dc.description.abstractObjective: The objective of this study is to investigate the urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in the second trimester of pregnant patients at the time of gestational diabetes mellitus (GDM) screening. Materials and methods: Urinary samples from 88 pregnant women who underwent gestational diabetes screening test were collected in late second trimester (24–28 weeks) prospectively. After an overnight fasting, 75 g GTT was performed. The blood samples were drawn for measurement of glucose, insulin, and HbA1c. The urinary and blood parameters were compared for pregnant women with or without gestational diabetes. Results: uNGAL levels were significantly elevated in pregnant women with gesting compared with the control groups (p < .014). There was a positive correlation between uNGAL and HbA1c levels (p ¼ .001). Conclusions: In the second trimester, at the time of GDM screening, high levels of uNGAL indicate tubular injury in GDM cases which seems to be a result of hyperglycemia. uNGAL may correlate with an inflammatory renal involvement in GDM.en_US
dc.relation.ispartofseriesThe Journal of Maternal-Fetal & Neonatal Medicine (31) 22;3039-3042
dc.subjectUrinary neutrophil gelatinase-associated lipocalinen_US
dc.subjectgestational diabetes mellitusen_US
dc.subjectsecond trimesteren_US
dc.titleSecond-trimester urinary neutrophil gelatinase-associated lipocalin levels in gestational diabetes: Preliminary resultsen_US
dc.departmentTıp Fakültesien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record